Search

Your search keyword '"Butt, Jawad"' showing total 926 results

Search Constraints

Start Over You searched for: Author "Butt, Jawad" Remove constraint Author: "Butt, Jawad"
926 results on '"Butt, Jawad"'

Search Results

3. Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER

9. Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER

10. All-cause mortality among Danish nursing home residents before and during the COVID-19 pandemic: a nationwide cohort study

12. Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study

19. Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum

22. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

23. Abstract 14120: Characteristics, Outcomes and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in People With HF and a History of CABG Surgery: A Pooled Analysis From DAPA-HF and DELIVER

24. Abstract 13026: Effects of Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy - A Patient-Level Meta-Analysis of DAPA-HF and DELIVER

25. Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial

26. Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH

29. Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction

31. Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction

32. Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF

33. Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality—a nationwide study

34. A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study

35. NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH Trial

36. Excess Risk of Mortality and Hospitalization in Patients with Heart Failure According to Age and Comorbidity – A Nationwide Register Study.

40. New York Heart Association functional class and implantable cardioverter‐defibrillator in non‐ischaemic heart failure with reduced ejection fraction: Extended follow‐up of the DANISH trial

41. Effect of implantable cardioverter-defibrillator in non-ischemic heart failure according to background medical therapy: Extended follow-up of the DANISH trial

42. Long-term Rate of Ventricular Arrhythmia in Autoimmune Disease

43. Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016

49. Dapagliflozin and Timing of Prior Heart Failure Hospitalization:A Patient-Level Meta-Analysis of DAPA-HF and DELIVER

50. Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin:A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER

Catalog

Books, media, physical & digital resources